A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection

Clinical trial NCT01316237 · COMPLETED

Trial details

NCT number

NCT01316237

Sponsor

Gilead Sciences

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-01-01

Primary completion

2011-10-01

Enrollment

90

View on ClinicalTrials.gov